NCT06037421 Metagenomic Analysis of Bacterial Microbiota in Breast Milk
| NCT ID | NCT06037421 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Sud Francilien |
| Condition | Bacteria in Breast Milk |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2025-09-08 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2025-09-08 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to determine the extent to which bacteria in the breast milk microbiota represent an infectious risk for premature infants, by investigating whether they possess virulence genes, and if so, whether these are expressed or repressed.
Eligibility Criteria
Inclusion Criteria: * Women of legal age who have given birth at the CHSF (or in another establishment) and whose newborn(s) are being cared for in the CHSF's Neonatal Medicine and Intensive Care Unit, * Women wishing to give their milk to their child, * Parents who have given their consent for the mother-child couple to take part in the study. Exclusion Criteria: * Mother having received antibiotic therapy in the 3 months prior to delivery, except for those who received injectable antibiotic prophylaxis during delivery.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06037421 clinical trial?
This trial is open to participants of all sexes, aged 1 Hour or older, studying Bacteria in Breast Milk. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06037421 currently recruiting?
Yes, NCT06037421 is actively recruiting participants. Contact the research team at didier.lecointe@chsf.fr for enrollment information.
Where is the NCT06037421 trial being conducted?
This trial is being conducted at Corbeil-Essonnes, France.
Who is sponsoring the NCT06037421 clinical trial?
NCT06037421 is sponsored by Centre Hospitalier Sud Francilien. The trial plans to enroll 120 participants.